Promentis Pharmaceuticals
Milwaukee
About Promentis Pharmaceuticals
Promentis Pharmaceuticals discovers, develops, and markets new drugs for the treatment of important human diseases, focusing initially on developing a new antipsychotic drug to treat schizophrenia. Promentis Pharmaceuticals was founded in 2006 and is based in Milwaukee, Wisconsin.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $63.9M
- Last round: Series Unknown (Dec 2019)
- Website: promentispharma.com
- Phone: (414)238-2992
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/promentis-pharmaceuticals-92114 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.